SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES


Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Herr Amy E.
(Last) (First) (Middle)
614 MCKINLEY PLACE NE
(Street)
MINNEAPOLIS MN 55413
(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
02/01/2025 		3. Issuer Name and Ticker or Trading Symbol
BIO-TECHNE Corp [ TECH ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 1,860 I By significant other
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy) (1) 08/08/2025 Common Stock 3,256 44.33 I By significant other
Stock Option (Right to Buy) (1) 08/07/2026 Common Stock 6,636 47.6 I By significant other
Stock Option (Right to Buy) (1) 08/05/2027 Common Stock 4,472 66.97 I By significant other
Stock Option (Right to Buy) (2) 08/06/2028 Common Stock 2,076 120.46 I By significant other
Stock Option (Right to Buy) (3) 08/15/2029 Common Stock 2,104 94.52 I By significant other
Stock Option (Right to Buy) (4) 08/15/2030 Common Stock 1,084 84.61 I By significant other
Stock Option (Right to Buy) (5) 08/15/2034 Common Stock 1,468 74.91 I By significant other
Restricted Stock Units (6) (6) Common Stock 237 (7) I By significant other
Restricted Stock Units (8) (8) Common Stock 480 (7) I By significant other
Explanation of Responses:
1. Fully vested.
2. 520 shares vest on each of 8/6/2022, 8/6/2023 and 8/6/2025; and 516 shares vest on 8/6/2024.
3. 528 shares vest on 8/15/2023 and 8/15/2025; 524 shares vest on 8/15/2024 and 8/15/2026.
4. 271 shares vest on each of 8/15/2024, 8/15/2025, 8/15/2026 and 8/15/2027.
5. 367 shares vest on each of 8/15/2025, 8/15/2026, 8/15/2027 and 8/15/2028.
6. 119 restricted stock units vest on 8/15/2025 and 118 restricted stock units vest on 8/15/2026.
7. Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
8. 160 restricted stock units vest on each of 8/15/2025, 8/15/2026 and 8/15/2027.
Andrew Nick as Attorney-in-Fact for Amy E. Herr pursuant to Power of Attorney filed herewith. 02/07/2025
** Signature of Reporting Person Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.